US 8232406
c-MET protein kinase inhibitors
granted A61PA61P1/16A61P11/00
Quick answer
US patent 8232406 (c-MET protein kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jul 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P1/16, A61P11/00, A61P19/04, A61P19/10